Cancer vaccine could be available by 2030, COVID vax-makers say
New York PostJUL 2022
Cancer vaccine research hasn't been very successful due to cycle times taking too long, which is why this study is such a breakthrough. The use of mRNA technology not only allows a quicker process but a personalized one in which individual patients' tumor DNA can be used to attack specific cancer cell mutations harming their immune systems.
This is all positive news, but we shouldn't get ahead of ourselves over just one headline. While promising, potentially successful cancer vaccines like this face many challenges and are still years away from being rolled out. Further research is needed.